Source: Health Canada shortage reports · Updated Jul 20, 2026
Some Eletriptan products are in shortage in Canada (2 of 18 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Sep 29, 2026.
A triptan used to relieve migraine attacks once they have started.
Products affected
2 / 18
In shortage since
May 21, 2026
Est. full return
Sep 29, 2026
Reports on file
48
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
RELPAX
20MG · TABLET · BGP PHARMA ULC
DIN 02256290 · since May 21, 2026, est. end Sep 29, 2026 · Disruption of the manufacture of the drug.
Active shortage
MYLAN-ELETRIPTAN
20MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02342235 · since Jun 1, 2026, est. end Sep 29, 2026 · Disruption of the manufacture of the drug.
Resolved
JAMP ELETRIPTAN
40MG · TABLET · JAMP PHARMA CORPORATION
DIN 02493691 · ended Mar 12, 2026 · Disruption of the manufacture of the drug.
Resolved
JAMP ELETRIPTAN
20MG · TABLET · JAMP PHARMA CORPORATION
DIN 02493683 · ended Mar 12, 2026 · Disruption of the manufacture of the drug.
Resolved
ELETRIPTAN
20MG · TABLET · SANIS HEALTH INC
DIN 02511266 · ended May 13, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-ELETRIPTAN
20MG · TABLET · TEVA CANADA LIMITED
DIN 02382091 · ended Apr 15, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-ELETRIPTAN
20MG · TABLET · TEVA CANADA LIMITED
DIN 02382091 · ended Aug 7, 2025 · Disruption of the manufacture of the drug.
Resolved
RELPAX
40MG · TABLET · BGP PHARMA ULC
DIN 02256304 · ended Feb 27, 2025 · Quality Delay
Resolved
ELETRIPTAN
20MG · TABLET · SANIS HEALTH INC
DIN 02511266 · ended Jan 29, 2025 · Disruption of the manufacture of the drug.
Resolved
ELETRIPTAN
20MG · TABLET · SANIS HEALTH INC
DIN 02511266 · ended Nov 27, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-ELETRIPTAN TABLETS
40MG · TABLET · APOTEX INC
DIN 02518023 · ended Nov 21, 2024 · Disruption of the manufacture of the drug.
Resolved
JAMP ELETRIPTAN
40MG · TABLET · JAMP PHARMA CORPORATION
DIN 02493691 · ended Apr 26, 2024 · Disruption of the manufacture of the drug.
Showing 12 of 48 reports. All reports are on file with Health Canada.
What's happening
Eletriptan is currently affected by 2 active shortage reports filed with Health Canada by BGP PHARMA ULC, MYLAN PHARMACEUTICALS ULC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Eletriptan is classified under “ANTIMIGRAINE PREPARATIONS” (ATC N02CC).
Recent changes
Jul 20, 2026
Estimated end date pushed back : Jul 28, 2026 → Sep 29, 2026
Jul 20, 2026
New report filed
Common questions
What is Eletriptan used for?
A triptan used to relieve migraine attacks once they have started.
When will Eletriptan be back in stock in Canada?
The latest manufacturer estimate is Sep 29, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Eletriptan in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.